AI BriefingAnthropic Acquires Biotech Startup Coefficient Bio for $400 Million
Key point
Anthropic acquired biotech AI startup Coefficient Bio for $400 million, expanding into the healthcare sector.
Details
Anthropic has acquired stealth biotech AI startup Coefficient Bio through a stock deal valued at $400 million.
This acquisition is part of Anthropic's strategic push to expand into healthcare and life sciences, following the announcement of Claude for Life Sciences last October to support scientific research.
Coefficient Bio was founded by researchers from Genentech and holds technology that uses AI to improve the efficiency of drug development and biology research.
The acquired team of about 10 people will join Anthropic's Health and Life Sciences team.
This summary was generated automatically by AI. Check the original for the author's claims and context. Copyright belongs to the original author.
Our guide explains how the AI works. Report summary errors, attribution issues, or removal requests via Contact.
Related
Anthropic Considering 'Claude Money' Tab for Personal Finance in Mobile Claude AppAnthropic, Google, and OpenAI Launch Frontier Models in Dual 'Public-Vetted' Releases; Safety Guardrails and Access Controls as Key Differentiators